Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 200 of 285 entries
View as:

A Phase II Study of Faropenem in the Treatment of Adult Community-acquired Bacterial Pneumonia

Phase: N/A Priority: Normal
NCT ID: NCT01886053 Org: User:
Start: 04/30/11 End: 07/31/12 Due: 07/31/13

A Study of Anlotinib Hydrochloride Capsule Combined With AK105 Injection in Subject With Advanced Gastric and Gastro-oesophageal Junction Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04385550 Org: User:
Start: 05/20/20 End: 12/31/23 Due: 12/31/24

A Phase III Study of Faropenem in the Treatment of Adult Community-acquired Bacterial Pneumonia

Phase: N/A Priority: Normal
NCT ID: NCT01937832 Org: User:
Start: 10/31/13 End: - Due: -

Anlotinib Hydrochloride Capsules Combined With TQB2450 in the Treatment of Endometrial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06475599 Org: User:
Start: 07/31/24 End: 06/30/29 Due: 06/30/30

A Clinical Trial of TQB3454 Tablets in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT06139367 Org: User:
Start: 11/30/23 End: 12/31/23 Due: 12/31/24

A Clinical Study to Evaluate the Efficacy and Safety of TQB3702 Tablets Combined With Immunochemotherapy for the Treatment of B-cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT06566586 Org: User:
Start: 11/06/24 End: 12/31/27 Due: 12/31/28

A Study of TQB2450 in Combination With Intensity-modulated Radiotherapy in Patients With Inoperable Locally Recurrent Nasopharyngeal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04895345 Org: User:
Start: 06/15/21 End: 04/29/24 Due: 04/29/25

A Study of TQA3526 in the Treatment of Primary Biliary Cirrhosis (PBC)

Phase: N/A Priority: Normal
NCT ID: NCT04278820 Org: User:
Start: 03/20/20 End: 11/30/22 Due: 11/30/23

A Clinical Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus K Drug in the Treatment of First-line Non-small Cell Lung Cancer(NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT04964479 Org: User:
Start: 08/06/21 End: 03/31/23 Due: 03/31/24

Clinical Study to Compare the Pharmacokinetics and Safety of Ramucirumab Injection With Cyramza ® in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT05800418 Org: User:
Start: 11/04/19 End: 02/18/20 Due: 02/18/21

Study of Anlotinib in Patients With Gastric Cancer(ALTER0503)

Phase: N/A Priority: Normal
NCT ID: NCT02461407 Org: User:
Start: 06/30/15 End: 12/31/17 Due: 12/31/18

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of TQ-B3234 in Patients With Type I Neurofibromatosis

Phase: N/A Priority: Normal
NCT ID: NCT05107037 Org: User:
Start: 11/30/21 End: 12/31/24 Due: 12/31/25

A Clinical Trial on the Safety and Efficacy of TQB3909 Tablets in Patients With Recurrent or Refractory Chronic Lymphocytic Leukemia (CLL) /Small Lymphocytic Lymphoma (SLL) .

Phase: N/A Priority: Normal
NCT ID: NCT05959694 Org: User:
Start: 10/11/23 End: 06/30/26 Due: 06/30/27

Efficacy and Safety of Angiotensin II Injection Versus Placebo in Patients With Refractory Distributed Shock

Phase: N/A Priority: Normal
NCT ID: NCT06351150 Org: User:
Start: 07/23/24 End: 12/31/27 Due: 12/31/28

Efficacy and Safety of Colistimethate Sodium Injection Vial to Treat Hospital-acquired Pneumonia in Adults

Phase: N/A Priority: Normal
NCT ID: NCT01940731 Org: User:
Start: 10/31/13 End: - Due: -

Tolerability and Pharmacokinetics Study of TQB3702 Tablets in Hematologic Tumor Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05610202 Org: User:
Start: 11/30/22 End: 08/31/24 Due: 08/31/25

Study of Polyglycan Superparamagnetic Ferric Oxide Injection on Cardiovascular Magnetic Resonance Imaging

Phase: N/A Priority: Normal
NCT ID: NCT05687864 Org: User:
Start: 06/17/23 End: 12/31/23 Due: 12/31/24

Study of Anlotinib in Patients With Small Cell Lung Cancer (ALTER1202)

Phase: N/A Priority: Normal
NCT ID: NCT03059797 Org: User:
Start: 03/27/17 End: 05/06/19 Due: 05/06/20

A Clinical Trial of TQC3721 Suspension for Inhalation

Phase: N/A Priority: Normal
NCT ID: NCT05051930 Org: User:
Start: 10/18/21 End: 12/31/22 Due: 12/31/23

A Study of Anlotinib and AK105 Injection in Subjects With Gastrointestinal Tumors, Urinary System Tumors, Neuroendocrine Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04207463 Org: User:
Start: 06/03/20 End: 05/30/21 Due: 05/30/22

A Clinical Trial of TQC3721 Suspension for Inhalation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease.

Phase: N/A Priority: Normal
NCT ID: NCT05987371 Org: User:
Start: 08/23/23 End: 04/23/24 Due: 04/23/25

Clinical Study to Compare the Pharmacokinetics and Safety of Trastuzumab for Injection With Herceptin® in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT05765357 Org: User:
Start: 07/16/17 End: 10/27/17 Due: 10/27/18

D-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Standard Therapy Failure

Phase: N/A Priority: Normal
NCT ID: NCT06300177 Org: User:
Start: 03/28/24 End: 12/31/27 Due: 12/31/28

A Study to Evaluate the Tolerance, Efficacy and Pharmacokinetics of TQB3454 Tablets

Phase: N/A Priority: Normal
NCT ID: NCT04481607 Org: User:
Start: 08/24/20 End: 12/31/22 Due: 12/31/23

Tolerance and Pharmacokinetics of TQ-B3233

Phase: N/A Priority: Normal
NCT ID: NCT03453034 Org: User:
Start: 11/22/17 End: 12/31/18 Due: 12/31/19